Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-209728
Filing Date
2018-06-29
Accepted
2018-06-29 16:27:09
Documents
4
Effectiveness Date
2018-06-29

Document Format Files

Seq Description Document Type Size
1 S-8 d630281ds8.htm S-8 43215
2 EX-5.1 d630281dex51.htm EX-5.1 8876
3 EX-23.1 d630281dex231.htm EX-23.1 1561
4 GRAPHIC g630281dsp007.jpg GRAPHIC 2178
  Complete submission text file 0001193125-18-209728.txt   58000
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-226004 | Film No.: 18929601
SIC: 2834 Pharmaceutical Preparations